Quantum biopharma engages mz group to lead strategic investor relations and shareholder communications program

Toronto, feb. 11, 2025 (globe newswire) -- quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fra: 0k91) (upstream: qntm) (“quantum biopharma” or the “company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced it has retained the services of mzhci, llc, an mz group company (“mz”), to lead a comprehensive strategic investor relations and financial communications program across all key markets.
QNTM Ratings Summary
QNTM Quant Ranking